RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND LOW-DOSE CYTOSINE-ARABINOSIDE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME - A PILOT-STUDY

被引：24
|
作者：
GANSER, A [1 ]
OTTMANN, OG [1 ]
SCHULZ, G [1 ]
HOELZER, D [1 ]
机构：
[1] BEHRINGWERKE AG,DEPT CLIN RES,D-3550 MARBURG,FED REP GER
来源：
ONKOLOGIE | 1989年 / 12卷 / 01期
关键词：
D O I：
10.1159/000216589
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：13 / 15
页数：3
相关论文
共 50 条
  • [41] Immune-stimulating effects of low-dose perioperative recombinant granulocyte-macrophage colony-stimulating factor in patients operated on for primary colorectal carcinoma
    Mels, AK
    Muller, MGS
    van Leeuwen, PAM
    von Blomberg, BME
    Scheper, RJ
    Cuesta, MA
    Beelen, RHJ
    Meijer, S
    [J]. BRITISH JOURNAL OF SURGERY, 2001, 88 (04) : 539 - 544
  • [42] TREATMENT WITH RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF) IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    GANSER, A
    OTTMANN, OG
    VOLKERS, B
    WALTHER, F
    BECHER, R
    BERGMANN, L
    HOELZER, D
    [J]. EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 520 - 520
  • [43] RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES - A PHASE-I/II TRIAL
    GANSER, A
    VOLKERS, B
    GREHER, J
    WALTHER, F
    HOELZER, D
    [J]. ONKOLOGIE, 1988, 11 (01): : 53 - 55
  • [44] BIOLOGIC PROPERTIES INVITRO OF A RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
    METCALF, D
    BEGLEY, CG
    JOHNSON, GR
    NICOLA, NA
    VADAS, MA
    LOPEZ, AF
    WILLIAMSON, DJ
    WONG, GG
    CLARK, SC
    WANG, EA
    [J]. BLOOD, 1986, 67 (01) : 37 - 45
  • [45] PHASE-I/II STUDY OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN APLASTIC-ANEMIA AND MYELODYSPLASTIC SYNDROME
    ANTIN, JH
    SMITH, BR
    HOLMES, W
    ROSENTHAL, DS
    [J]. BLOOD, 1988, 72 (02) : 705 - 713
  • [46] Effect of recombinant human erythropoietin combined with granulocyte/macrophage colony-stimulating factor in the treatment of patients with myelodysplastic syndrome
    Thompson, JA
    Gilliland, DG
    Prchal, JT
    Bennett, JM
    Larholt, K
    Nelson, RA
    Rose, EH
    Dugan, MH
    [J]. BLOOD, 2000, 95 (04) : 1175 - 1179
  • [47] Treatment of high risk myelodysplastic syndromes with idarubicin and cytosine arabinoside supported by granulocyte-macrophage colony-stimulating factor (GM-CSF)
    Economopoulos, T
    Papageorgiou, E
    Stathakis, N
    Constantinidou, M
    Parharidou, A
    Kostourou, A
    Dervenoulas, J
    Raptis, S
    [J]. LEUKEMIA RESEARCH, 1996, 20 (05) : 385 - 390
  • [48] STIMULATION OF HEMATOPOIESIS IN PRIMATES WITH RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
    DONAHUE, RE
    NIENHUIS, AW
    WONG, GG
    NATHAN, DG
    CLARK, SC
    [J]. JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1987, 6 (02): : 219 - 219
  • [49] POTENTIAL USES OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN CHILDREN
    FURMAN, WL
    CRIST, WM
    [J]. AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1991, 13 (04): : 388 - 399
  • [50] Pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor: The effects of zidovudine
    Aweeka, FT
    Kwong, M
    Mak, M
    AlUzri, A
    Affrime, M
    Cutler, D
    Kahn, J
    Gambertoglio, JG
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (12): : 1107 - 1113
12345